AMRX (Amneal Pharmaceuticals, Inc.) — Stock Analysis, Catalysts & AI Research

Amneal Pharmaceuticals, Inc.

$17.80

Health CareDrug Manufacturers - Specialty & Generic

The Read: 6% on FDA approval of complex generics before a muted 0.

AMRX

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Amneal Pharmaceuticals, Inc.

$17.80

Health CareDrug Manufacturers - Specialty & Generic

The Read: 6% on FDA approval of complex generics before a muted 0.

AMRX

Hover to view data

No Data

The Stats

Market Cap

N/A

Total outstanding shares value

Earnings Per Share (EPS)

N/A

Latest reported

Net Profit Margin

N/A

Net Income / Revenue

Revenue Growth (YoY)

N/A

Prior year same period

Debt / Equity

N/A

Leverage risk indicator

Dividend Yield

0.00%

Annualized Return

Free Cash Flow

N/A

No data

Start your free trial to unlock active Expected Moves for AMRX

Expected Moves

Amneal Pharmaceuticals, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow

Start your free trial to unlock active Expected Moves for AMRX

Expected Moves

Amneal Pharmaceuticals, Inc.

The Stats

Market Cap

Earnings Per Share (EPS)

Net Profit Margin

Revenue Growth (YoY)

Debt / Equity

Dividend Yield

Free Cash Flow